Skip to Content

Enhanze SC Approval Status

FDA Approved: No
Brand name: Enhanze SC
Generic name: recombinant human hyaluronidase
Company: Halozyme Therapeutics, Inc.
Treatment for: Drug Delivery

Enhanze SC is a local formulation of recombinant human hyaluronidase intended for use as a "spreading agent" to enhance the drug delivery of local anesthesia, contrast agents, and for subcutaneous fluid replacement (also called hypodermoclysis).

Development Status and FDA Approval Process for Enhanze SC

DateArticle
Mar 28, 2005Halozyme Therapeutics Files NDA for Enhanze SC

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide